Fred Hutchinson Cancer Research Center [clinicaltrials_resource:0413b67bb11aa7435c2cb6e1a4385dec]
Daniel W Lin, MD [clinicaltrials_resource:02fde5b80b0db6975277792de5e12b39]Antonio Pellicer, MDPhD [clinicaltrials_resource:04d4442faff5f7e35e194ccdd801cc11]Derek L. Stirewalt, MD [clinicaltrials_resource:052f2be4fde4c66ce9e7223588368a91]Jerry Radich, MD [clinicaltrials_resource:073fe9a3b6b014c29d9c7d68188ff654]Karen Syrjala, MD [clinicaltrials_resource:0d533a29f4e693902fa2b5b6956dcb98]Douglas Hawkins, MD [clinicaltrials_resource:11046970acb1f734a88564f6b75cf50e]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Andrea Z LaCroix, PhD [clinicaltrials_resource:15bcb2a28afbc14d10cdce1366e7dcdb]Erica Andersen-Nissen, PhD [clinicaltrials_resource:15ccae902124f4015fb68fe4ecc5b382]Jonathan Bricker, PhD [clinicaltrials_resource:18306fc146cd658ab2ddd63b84158fda]Derek L. Stirewalt, MD [clinicaltrials_resource:1922870440bfa2ef8ee399dc4a9d4ff0]Colleen Delaney, MD, MSC [clinicaltrials_resource:1994b2fc08d02c5f79cdc20e253e436a]Paul Carpenter, MD [clinicaltrials_resource:1a0e6ddb5def387599285864c844b5d7]Hans-Peter Kiem, MD [clinicaltrials_resource:1aac5e5dad9c5e141c593845725aa8a4]Sangeeta R. Hingorani, MD, MPH [clinicaltrials_resource:1cefc9b05020989aa62784038bcd3c6b]Jeannine S McCune, PharmD [clinicaltrials_resource:1d3f904def768f60ddb6f1f1f16890c2]Marian Neuhouser, RD, PhD [clinicaltrials_resource:202593081e588b5e31d7f1fd0e81efc1]David G. Maloney, MD, PhD [clinicaltrials_resource:21ed0b55dbe2d4a1a2cf0834dbeff206]Brenda Sandmaier, MD [clinicaltrials_resource:23d1433d8acd95d707b3c46ee670a970]Ross Prentice [clinicaltrials_resource:27a36585ef559d87870a7988b57229a1]Jeanne E. Anderson, MD [clinicaltrials_resource:280faebfffff77e46fc10dce202aef59]Jean E. Sanders, MD [clinicaltrials_resource:292cb0291f3ad94eff90feb2378e2bd7]Paul Martin [clinicaltrials_resource:2aab56b2c3c424bbe5d4b0cd4545fa93]Scott D. Ramsey, M.D. [clinicaltrials_resource:2c254e2e37e64fef595e42eef77b200f]Roland Walter [clinicaltrials_resource:313836a36d92011c1013a15b321ace11]Johanna Lampe, PhD Rd [clinicaltrials_resource:317b03b6d87c3e1d713314de6bc16871]Joachim Deeg, M.D. [clinicaltrials_resource:359e4dc25e8d4ba117d4dfe73a4302b8]Eric Sievers, MD [clinicaltrials_resource:3613879c76a4064f7ffbfe7eb6505206]Michael Boeckh, MD [clinicaltrials_resource:36a841c90b05efe147c17b81569f1699]Stephanie J Lee, MD MPH [clinicaltrials_resource:38fa01493d75ef5ee0102ea8b3bb6067]Marian Neuhouser, PhD [clinicaltrials_resource:3b697a5864fa0eeb9dd065f867b859de]Anne McTiernan, MD, PhD [clinicaltrials_resource:3bdf7f3d1ac85f192b28afb0663617ae]Claudio Anasetti, MD [clinicaltrials_resource:3fdf00b29cbe75954d5b09fa7f862f0e]Ann Duerr, M.D. [clinicaltrials_resource:401ecbbca192641aa5dd00daaec685f6]Nicole Urban, ScD [clinicaltrials_resource:404c1575e9d1047524f38d43b66df2c8]Ann Duerr, M.D. [clinicaltrials_resource:43348de55a8dc3a0ba7e0d815470fa04]Jonathan B Bricker, Ph.D. [clinicaltrials_resource:4414db28a7b83cd8602570ae7796d409]Marco B. Mielcarek, MD [clinicaltrials_resource:441dfd961b9826743188947b3cd17f1d]Johanna Lampe, PhD Rd [clinicaltrials_resource:48fa86263e28c703b86d8aaab0fec392]Richard Nash, MD [clinicaltrials_resource:4ae1a700a454b847d3d72fb2f5f562ac]
affiliation [clinicaltrials_vocabulary:affiliation]
Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00002553]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002674]Biological Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002786]High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia [clinicaltrials:NCT00002788]Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00002789]Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [clinicaltrials:NCT00002790]Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders [clinicaltrials:NCT00002792]Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission [clinicaltrials:NCT00002977]Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer [clinicaltrials:NCT00003080]Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma [clinicaltrials:NCT00003081]Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00003145]Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003146]Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003195]Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma [clinicaltrials:NCT00003196]Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer [clinicaltrials:NCT00003199]Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia [clinicaltrials:NCT00003868]Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia [clinicaltrials:NCT00003870]Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia [clinicaltrials:NCT00003874]Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00003875]Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation [clinicaltrials:NCT00003883]Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation [clinicaltrials:NCT00003887]Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00003899]Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease [clinicaltrials:NCT00003913]Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma [clinicaltrials:NCT00003954]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer [clinicaltrials:NCT00003972]Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer [clinicaltrials:NCT00004013]Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors [clinicaltrials:NCT00004157]Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00004158]Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [clinicaltrials:NCT00005799]Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia [clinicaltrials:NCT00005802]Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma [clinicaltrials:NCT00005803]Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00005804]Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer [clinicaltrials:NCT00005851]Biological Therapy in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00005853]Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00005854]Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission [clinicaltrials:NCT00005940]Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer [clinicaltrials:NCT00005941]Chemotherapy Followed by Peripheral Stem Cell Transplantation And Biological Therapy in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00005948]Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00006233]Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Ewing's Sarcoma or Rhabdomyosarcoma That Has Spread to the Bone [clinicaltrials:NCT00006234]
collaborator [clinicaltrials_vocabulary:collaborator]
Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00002456]Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00002553]Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse [clinicaltrials:NCT00002554]Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation [clinicaltrials:NCT00002673]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002674]Biological Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002786]High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia [clinicaltrials:NCT00002788]Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00002789]Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [clinicaltrials:NCT00002790]Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders [clinicaltrials:NCT00002792]Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission [clinicaltrials:NCT00002977]Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer [clinicaltrials:NCT00003080]Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma [clinicaltrials:NCT00003081]Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00003145]Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003146]Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003195]Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma [clinicaltrials:NCT00003196]Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer [clinicaltrials:NCT00003199]Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia [clinicaltrials:NCT00003868]Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia [clinicaltrials:NCT00003870]Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia [clinicaltrials:NCT00003874]Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00003875]Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation [clinicaltrials:NCT00003883]Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation [clinicaltrials:NCT00003887]Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00003899]Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease [clinicaltrials:NCT00003913]Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma [clinicaltrials:NCT00003954]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer [clinicaltrials:NCT00003972]Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer [clinicaltrials:NCT00004013]Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors [clinicaltrials:NCT00004157]Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00004158]Bone Marrow Transplantation in Treating Children With Sickle Cell Disease [clinicaltrials:NCT00004485]Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [clinicaltrials:NCT00005799]Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia [clinicaltrials:NCT00005802]Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma [clinicaltrials:NCT00005803]Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00005804]Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer [clinicaltrials:NCT00005851]Biological Therapy in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00005853]Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00005854]Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission [clinicaltrials:NCT00005940]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Danny Shen, PhD, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:01ab89c6fd521bb0078ca140403a427b]Jeannine S. McCune, PharmD, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:09deb1c6f3b10f5dbc5573cb9329d106]Anne McTiernan, MD, PhD, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:0fd6bff0e4be0f7ed7ed2e98bf8c203e]Jonathan Bricker, PhD, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:102e62fd7373972d0dda8297f30275cd]K. S. Baker, MD, MS, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:1575b2f08e1f1dad54d07742a70f50c0]Shirley A.A. Beresford, PhD, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:2bf60640bdf63072cb3e29122263c145]Press, Oliver MD, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:44f5bef6380ed443fe5619902e065133]Hans-Peter Kiem, MD, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:456e015fc17f8ec0203ad9888d390714]Marco B. Mielcarek, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:4db5bd22f55065f8e7c08470bf00d3bf]Mark Boyer, Director of Sponsored Research, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:507e363a09f6c0e6a4b7e343eac48b79]Bart L. Scott, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:5621d922d23537345a1296b4aeef8012]Gary Goodman, MD, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:635629f75aa35e6b1a0226360a91a7de]Cassian Yee, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:7b0508dd248f9f32165bcb2b0db5d5f5]Nicole Urban, ScD, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:823615825d31e5aa786dbbf633aa30f5]Brenda Sandmaier, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:86523bfe60081f8f77d1d3a891381d71]Ann Woolfrey / Associate in Clinical Research, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:8902230c006fa4e099881dde5b161e9c]Ann E. Woolfrey, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:a49029dc584065396592618bed88a7a5]Marian Neuhouser, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:a4b513be8738c469d4c81aec3cafb87c]Jerry Radich, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:a62684e37ac73e041db4a519ad215d9e]Anna Wald, MD, MPH, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:aa7ee4f8afdf25c625f02430005af50a]Arthur V. Peterson, Jr., PhD, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:bdea0c30cb58324f8e1d608b69bc134a]Roland Walter, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:ca36660ea14c08226f97d7fcf4e1d234]Leona A. Holmberg, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:cb5794009e469e830c84502860959290]Andrea LaCroix, Garnet Anderson, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:cd84abf5284068fd213fb20c0883a733]Kiem, Hans-Peter, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:cdd72cadd92e970b21f75ebfe97fd643]William I. Bensinger, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:d6dfc97bcdecb6e29524ab5453662c05]Shirley A. A. Beresford, PhD, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:e44a78d88268edbd974c44ca34e844a5]Bonnie A. McGregor, PhD / Assistant Member, Fred Hutchinson Cancer Research Center [clinicaltrials_resource:f743248178c705be1e8744dc1a159056]
organization [clinicaltrials_vocabulary:organization]
Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00002456]Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00002553]Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse [clinicaltrials:NCT00002554]Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation [clinicaltrials:NCT00002673]Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002674]Biological Therapy in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00002786]Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation [clinicaltrials:NCT00002787]High-Dose Chemotherapy Followed by Total-Body Irradiation and Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia [clinicaltrials:NCT00002788]Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00002789]Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant [clinicaltrials:NCT00002790]Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders [clinicaltrials:NCT00002792]Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission [clinicaltrials:NCT00002977]Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer [clinicaltrials:NCT00003080]Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma [clinicaltrials:NCT00003081]Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00003145]Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003146]Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00003195]Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma [clinicaltrials:NCT00003196]Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer [clinicaltrials:NCT00003199]Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia [clinicaltrials:NCT00003868]Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia [clinicaltrials:NCT00003870]Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia [clinicaltrials:NCT00003874]Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia [clinicaltrials:NCT00003875]Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation [clinicaltrials:NCT00003883]Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation [clinicaltrials:NCT00003887]Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00003899]Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease [clinicaltrials:NCT00003913]Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma [clinicaltrials:NCT00003954]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer [clinicaltrials:NCT00003972]Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer [clinicaltrials:NCT00004013]Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors [clinicaltrials:NCT00004157]Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00004158]Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer [clinicaltrials:NCT00005799]Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia [clinicaltrials:NCT00005802]Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma [clinicaltrials:NCT00005803]Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00005804]Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer [clinicaltrials:NCT00005851]Biological Therapy in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00005853]Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00005854]Radiolabeled BC8 Antibody, Busulfan, Cyclophosphamide Followed by Donor Stem Cell Transplant in Treating Patients With Acute Myelogenous Leukemia in First Remission [clinicaltrials:NCT00005940]
source [clinicaltrials_vocabulary:source]
Fred Hutchinson Cancer Research Center [clinicaltrials_resource:0413b67bb11aa7435c2cb6e1a4385dec]
Bio2RDF identifier
0413b67bb11aa7435c2cb6e1a4385dec
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0413b67bb11aa7435c2cb6e1a4385dec
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:0413b67bb11aa7435c2cb6e1a4385dec
title
Fred Hutchinson Cancer Research Center
@en
type
label
Fred Hutchinson Cancer Researc ...... 3b67bb11aa7435c2cb6e1a4385dec]
@en